Physician profile
Charles Penvose
NPI 1144853649
$34,434.53
in general payments reported to CMS, 2019-2025
29 companies · $1,051 in 2025
The $1,051 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15K · 2022: $13K · 2023: $4,234 · 2024: $1,218 · 2025: $1,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,036 · Travel and Lodging: $2,221 · Education: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,035.91 |
| Travel and Lodging | $2,221.19 |
| Education | $245.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $13,797.27 | 2021-2022 | |
| Stryker Corporation | $7,292.42 | 2021-2025 | Prophecy, Hoffmann, Variax |
| Vilex LLC | $2,773.95 | 2022 | |
| Acumed LLC | $2,434.14 | 2021-2023 | Acumed, Osteomed |
| Cdc Medical LLC | $1,458.50 | 2022-2023 | |
| International Life Sciences | $1,297.10 | 2023 | |
| Paragon 28, INC. | $1,295.25 | 2021-2024 | Phantom Hindfoot, Mtp |
| Medline Industries LP | $1,222.73 | 2021 | |
| United Orthopedics LLC | $1,200.00 | 2021 | |
| Mid-Atlantic Surgical Systems, LLC | $318.87 | 2025 | |
| Smith+Nephew, INC. | $167.84 | 2023-2025 | Stravix Pl, Stravix, Grafix Pl |
| Linvatec Corporation | $146.26 | 2022 | |
| Sanara Medtech INC. | $146.16 | 2025 | Celleraterx |
| Kerecis Limited | $139.70 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Flower Orthopedics Coporation | $136.53 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $129.63 | 2023 | Truelok System, Tl-Hex Truelok Hexapod System |
| Treace Medical Concepts, INC. | $105.63 | 2024-2025 | |
| Averitas Pharma INC. | $94.68 | 2023-2025 | Qutenza |
| Paratek Pharmaceuticals, INC. | $93.91 | 2022-2024 | Nuzyra |
| Organogenesis INC. | $28.69 | 2022-2024 | |
| Vertex Pharmaceuticals Incorporated | $20.94 | 2025 | |
| Trice Medical, INC. | $20.43 | 2024 | |
| Nevro Corp. | $19.86 | 2023 | Senza |
| Depuy Synthes Sales INC. | $19.04 | 2025 | Motoband, Motoband Cp |
| Bioventus LLC | $18.95 | 2025 | Exogen Ultrasound Bone Healing System |
| Dynasplint Systems INC. | $18.89 | 2023 | Dynasplint |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.10 | 2023 | Jublia |
| Horizon Therapeutics Plc | $15.72 | 2023 | Krystexxa |
| Microaire Surgical Instruments LLC | $5.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Penvose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.